New medical technology helps stop traumatic bleeding on the battlefield
A new medical technology stops traumatic bleeding without requiring wound compression for Soldiers on the battlefield. Hemorrhaging is a leading cause of preventable death for Soldiers in combat.
The simplicity, potential for deployability and proposed affordability of this technology under development allows Soldiers to carry a life-saving solution in their pocket.
Through a project funded by the Defense Health Agency Small Business Innovation Research, or SBIR, program, Hybrid Plastics, the University of Mississippi Medical Center, Vanderbilt University and Ichor Sciences developed StatBond, which treats uncontrolled bleeding from noncompressible areas of the body that include the groin, trunk, armpit, neck and internal organs. Currently, there is no battlefield treatment for such bleeding because these injuries are not responsive to the compression dressings currently carried by Soldiers and medics.
Date Time
Our Immune Systems Blanket SARS-CoV-2 Spike Protein with Antibodies
AUSTIN, Texas – The most complete picture yet is coming into focus of how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal Science, researchers at The University of Texas at Austin describe the finding, which represents good news for designing the next generation of vaccines to protect against variants of the virus or future emerging coronaviruses.
Previous research focused on one group of antibodies that target the most obvious part of the coronavirus’s spike protein, called the receptor-binding domain (RBD). Because the RBD is the part of the spike that attaches directly to human cells and enables the virus to infect them, it was rightly assumed to be a primary target of the immune system. But, testing blood plasma samples from four people who recovered from SARS-CoV-2 infections, the resear
E-Mail
IMAGE: An analysis of blood plasma samples from four people who recovered from SARS-CoV-2 infectionsshows that most of the antibodies circulating in the blood on average, about 84% target. view more
Credit: University of Texas at Austin
The most complete picture yet is coming into focus of how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal
Science, researchers at The University of Texas at Austin describe the finding, which represents good news for designing the next generation of vaccines to protect against variants of the virus or future emerging coronaviruses.
A new medical technology stops traumatic bleeding without requiring wound compression for Soldiers on the battlefield. Hemorrhaging is a leading cause of preventable death for Soldiers in combat.
The simplicity, potential for deployability and proposed affordability of this technology under development allows Soldiers to carry a life-saving solution in their pocket.
Mark your calendar for the May Manufacturing Lunch + Learn
Don’t miss this exclusive opportunity to engage with top industry suppliers!
To help you stay connected and informed throughout 2021, GIE Media’s Manufacturing Group is excited to announce the next edition of the
Manufacturing Lunch + Learn webinar series, which will take place from 12-1 P.M. ET on May 20. Explore the latest products, technologies, and services disrupting the industry and join us for this next educational session, featuring presentations led by HEIDENHAIN Corporation and OPEN MIND Technologies USA. Attendees can also connect with industry leaders to get answers to their specific questions during a live Q&A.